Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
32,915
Sort by:
Thymidylate synthase inhibitors - Pipeline Insight, 2022
US$ 2,000.00
This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “Thymidylate synthase inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 18+ compa...
January 2022
60 pages
Thyroid Eye Disease (TED) - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Thyroid Eye Disease (TED) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disea...
January 2022
60 pages
Thyroid hormone receptor agonists - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Thyroid Hormone Receptor Agonists - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies an...
January 2022
60 pages
Tick Borne Encephalitis - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Tick Borne Encephalitis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease...
January 2022
60 pages
TIE-2 receptor agonists - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 2-3 Business Days DelveInsight’s, “TIE-2 receptor agonists - Pipeline Insight, 2022” report provides comprehensive insights about 4+ companies and...
January 2022
60 pages
TIGIT inhibitors - Pipeline Insight, 2022
US$ 2,000.00
This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “TIGIT inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 14+ companies and 18+ pi...
January 2022
60 pages
TIL therapy - Pipeline Insight, 2022
US$ 2,000.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “TIL Therapy - Pipeline Insight, 2022” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs i...
January 2022
120 pages
Tinea Pedis - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Tinea Pedis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical...
January 2022
60 pages
Tinnitus - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Tinnitus - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical an...
January 2022
60 pages
Tonic clonic Seizure - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Tonic clonic Seizure - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, h...
January 2022
60 pages
TRAIL receptor 2 agonists - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 2-3 Business Days DelveInsight’s, “TRAIL receptor 2 agonists - Pipeline Insight, 2022” report provides comprehensive insights about 5+ companies an...
January 2022
60 pages
Transient Ischemic Attack - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Transient Ischemic Attack - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disea...
January 2022
60 pages
Transitional Cell Carcinoma - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Transitional Cell Carcinoma - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dis...
January 2022
60 pages
Transverse Myelitis - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Transverse Myelitis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hi...
January 2022
60 pages
Treg cell-based Therapies - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Treg cell-based Therapies - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disea...
January 2022
60 pages
Trichomoniasis – Epidemiology Forecast to 2032 (US)
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Trichomoniasis (US) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hi...
January 2022
60 pages
Trichotillomania (TTM) - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Trichotillomania (TTM) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...
January 2022
60 pages
Trigeminal Neuralgia- Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Trigeminal Neuralgia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, h...
January 2022
60 pages
TRK Fusion Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'TRK Fusion Cancer - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hist...
January 2022
60 pages
Trk (TrkB) receptor antagonists - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Trk (TrkB) receptor antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 3+ companies and 3...
January 2022
60 pages
TrkC receptor antagonists - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 2-3 Business Days DelveInsight’s, “TrkC receptor antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 7+ companies an...
January 2022
60 pages
TRPV1 receptor antagonists - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “TRPV1 receptor antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 4+ companies and 4+ pip...
January 2022
60 pages
Tuberous Sclerosis Complex - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Tuberous Sclerosis Complex - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dise...
January 2022
60 pages
TYK2 kinase inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “TYK2 Kinase Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 15+ companies and 15+ pipel...
January 2022
60 pages
Type 1 Diabetes - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Type 1 Diabetes - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histor...
January 2022
60 pages
Type 2 Diabetes - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Type 2 Diabetes - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histor...
January 2022
60 pages
